ClinicalTrials.Veeva

Menu

Personalized Outreach for Equitable Treatment in Rheumatology (POET-Rheum)

University of British Columbia logo

University of British Columbia

Status

Not yet enrolling

Conditions

Rheumatoid Arthritis (RA)
Connective Tissue Disease
Inflammatory Arthritis
Psoriatic Arthritis (PsA)
Rheumatic Diseases

Treatments

Behavioral: Outreach
Behavioral: Honoraria

Study type

Interventional

Funder types

Other

Identifiers

NCT07022756
H24-03984

Details and patient eligibility

About

The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia.

The main question it aims to answer are:

  • Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic?
  • Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic?

The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach.

Participants will:

  • Undergo randomization to receive honoraria or honoraria and outreach services together
  • Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals
  • Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition

Full description

Our study aims to enhance the existing twice-monthly rheumatology clinic at the Pender Community Health Centre with a rheumatology-specific outreach service for patients with inflammatory arthritis. This service will be provided by a rheumatology subspecialty trainee under the supervision of two attending rheumatologists. This will consist of biweekly phone calls, text messages, or home visits as per the patient's preference, at times flexible to patient needs. This will be in addition to monthly in-person assessment and bloodwork monitoring with adjustment as clinically indicated by their treating rheumatologist. Outreach services will include management of medications and side effects, proactive screening for infections, coordination of rheumatologic and general healthcare with their Primary Care Provider, social service navigation, and reminders for appointments and lab monitoring. All participants will be provided with a $20 honorarium for each in-person assessment they attend as part of the study.

We will aim to enroll 20 participants between July 2025 and October 2025. Participants will be randomized to either honorarium with outreach or honorarium alone arms in a 1:1 fashion, stratified by housing status (unhoused and emergency sheltered in one strata, provisionally accommodated and stably housed in the second strata).

All enrolled participants will receive a $20 honorarium for each in-person assessment with completed monitoring bloodwork as requested by the treating rheumatologist. The program will last 6 months for each patient from time of enrolment, or until a patient chooses to leave the program, whichever is sooner. At baseline, participants will complete two surveys: one on their general health status, and one specific to their rheumatic disease. At the 3-month and 6-month visits, these surveys will be repeated, and a semi-structured interview will be completed to obtain feedback on the pilot program.

The outcomes of this study will inform how we can better care for those who live with inflammatory arthritis and are also marginalized by extreme poverty and/or housing instability. We plan on disseminating and discussing results with our participants, community members, inner city physicians, and rheumatologists. If there are specific positive themes or outcomes from the study, we will advocate for additional resources to permit long-term implementation and further study to confirm results, make further improvements to our program, and improve generalizability.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have a diagnosis of inflammatory arthritis secondary to an autoimmune rheumatic disease
  • Be attached to one of the Vancouver Coastal Health Community Health Centres for primary care
  • Be willing to attend in-person appointments at Pender Community Health Centre
  • Be at least 18 years of age and capable of consenting to participation
  • Be able to receive medical care in English.

Exclusion criteria

  • Have cognitive impairment or an untreated psychiatric condition that would severely impair ability to engage with outreach or treatment
  • Have no reasonably reliable method of contact (phone, email, social media, etc.)

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 3 patient groups

Honoraria Only
Active Comparator group
Description:
Participants in this arm of the study will only receive honoraria and not outreach
Treatment:
Behavioral: Honoraria
Honoraria and Outreach
Experimental group
Description:
Participants in this arm of the study will receive both honoraria and outreach services
Treatment:
Behavioral: Honoraria
Behavioral: Outreach
Historical Control
No Intervention group
Description:
The attendance rate to follow-up appointments among all patients with inflammatory arthritis due to a rheumatic disease at the Pender Rheumatology Clinic from Jan 2023 to Jun 2025.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Chu Ming (Alec) Yu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems